TAK

#483
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
17.8350 USD
+0.31%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
17.8300
17.8450
Jahresspanne
12.9900
18.8950
Tagesänderung
+0.31%
Monatliche Änderung
-2.59%
6 month change
+25.73%
Jahresänderung
+25.73%
Vorheriger Schlusskurs
17.7800
Eröffnung
17.8350
Bid
Ask
Tief
17.8300
High
17.8450
Volumen
69
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 27.7827 B
  • Employee 47 K
  • Founded N/A
  • CEO Christophe WeberChristophe Weber
  • Website www.takeda.com
  • Headquarter Japan
  • FIGI BBG000LF8708
  • Industry Arzneimittelhersteller – spezialisierte und Generika

Takeda Pharmaceutical Company Limited American Depositary Share

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.

Nachrichten